Alexion Pharmaceuticals, Inc.’s Post

Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease characterised by unpredictable relapses that can lead to long-term disability. Learn why relapse prevention is critical for patients.

We are in the front for patients ✨

To view or add a comment, sign in

Explore topics